SGP
SpyGlass Pharma, Inc.
25.60$
+2.7%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|
| – | +444.7% | -8.8% | +123.0% | -5.8% | |
| – | +587.7% | -9.1% | +132.9% | -6.7% | |
| – | +551.6% | -9.1% | +147.9% | -6.6% | |
| – | – | -9.0% | +133.6% | -6.7% | |
| – | – | +3.1% | +51.5% | +3.8% | |
| – | +155.7% | +0.2% | -96.1% | +33.8% | |
| – | -15.2% | +29.9% | -22.3% | +41.5% | |
| – | – | – | – | – | |
| – | -15.1% | +60.5% | +30.3% | +18.2% | |
| – | – | – | – | -7.1% | |
| – | – | – | – | – | |
| – | +4.7% | +0.0% | -40.4% | +67.8% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.